You probably won’t have to think for very long to come up with at least a few reasons to avoid Aurora Cannabis (NYSE:ACB) stock. Just look at the company’s latest quarterly release. There was another huge loss, a major write-off of goodwill, and — scariest of all — a revenue decline that’s projected to continue into the next quarter.
That’s three reasons to include on the list. Now, after a regulatory filing from the cannabis producer last week, there are over 7 million more reasons to avoid Aurora.
Spreading the wealth
Aurora submitted its proxy circular to the U.S. Securities and Exchange Commission on Oct. 1. This proxy circular included information for shareholders in advance of the company’s annual general meeting, which will be held virtually on Nov. 12, 2020….